billHR7116Event Thursday, January 15, 2026Analyzed

SEPSIS Act

Neutral

Summary

The SEPSIS Act (HR7116) was introduced in the House on 2026-01-15 and referred to the Energy and Commerce Committee. The bill authorizes CDC education campaigns and data collection on sepsis but does not specify any funding amount. The companion bill S1929 has been referred to the HELP Committee. At this early procedural stage with zero funding authorized, there is no direct revenue impact to any public company.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The SEPSIS Act authorizes CDC programs but no spending; it commands zero dollars.
  • 2.No public company has any direct revenue exposure to this bill.
  • 3.The companion bill S1929 is in the Senate HELP Committee, but without appropriations, the bill is a procedural placeholder.

Market Implications

No sector or company faces a direct revenue change from this bill as introduced. The CDC education campaign does not involve contracting with health systems or diagnostic makers. Until the bill is paired with an appropriation, it is not an investable event. Healthcare quality improvement proposals rarely move stock prices without a clear procurement or reimbursement mechanism.

Full Analysis

The SEPSIS Act (HR7116) was introduced on January 15, 2026, by Rep. Norcross (D-NJ-1) with original cosponsor Rep. Kean (R-NJ-7) and five additional bipartisan cosponsors. The bill has been referred to the House Committee on Energy and Commerce. The companion Senate bill S1929 has also been referred to the HELP Committee. The bill's findings note 1.7M annual sepsis cases and 350K deaths, citing Rory's Regulations in New York as a proven protocol. The bill text directs the CDC to maintain a sepsis team and lead education campaigns, and to improve pediatric sepsis data collection. The bill authorizes no specific dollar amount — it is an authorization to set up programs, not an appropriation. Funding would require a separate appropriations bill. There is no federal procurement mechanism or tax credit for private companies. The legislation is in the earliest procedural stage with zero funding authorized. No public company faces a direct revenue impact from this bill as currently drafted. The bipartisan cosponsorship and companion bill indicate moderate legislative momentum, but the lack of any funding mechanism means the bill has no near-term market impact on any sector beyond potential healthcare quality improvement.

Key Legislators

Rep. Norcross, Donald [D-NJ-1]

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →